Bitwise MARA Option Income Strategy ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch IMRA and buy or sell other stocks, ETFs, and their options commission-free!

About IMRA

Enliven Therapeutics, Inc. operates as a clinical stage precision oncology company. It is focused on the discovery and development of next-generation small molecule kinase inhibitors and advancing Enliven's pipeline of precision oncology product candidates. 

CEO
Samuel S. Kintz, MBA
CEOSamuel S. Kintz, MBA
Employees
62
Employees62
Headquarters
Boulder, Colorado
HeadquartersBoulder, Colorado
Founded
2019
Founded2019
Employees
62
Employees62

IMRA Key Statistics

AUM
AUM
Price-Earnings ratio
-9.93
Price-Earnings ratio-9.93
30-Day yield
30-Day yield
Average volume
276.47K
Average volume276.47K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$30.03
52 Week high$30.03
52 Week low
$15.96
52 Week low$15.96
Expense ratio
Expense ratio

Stock Snapshot

The current Bitwise MARA Option Income Strategy ETF(IMRA) stock price is $14.59, with a market capitalization of 713.98M. The stock trades at a price-to-earnings (P/E) ratio of -9.93.

On 2026-09-08, Bitwise MARA Option Income Strategy ETF(IMRA) stock opened at —, reached a high of —, and a low of —.

The Bitwise MARA Option Income Strategy ETF(IMRA)'s current trading volume is 0, compared to an average daily volume of 276.47K.

During the past year, Bitwise MARA Option Income Strategy ETF(IMRA) stock moved between $15.96 at its lowest and $30.03 at its peak.

During the past year, Bitwise MARA Option Income Strategy ETF(IMRA) stock moved between $15.96 at its lowest and $30.03 at its peak.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.